Previous Article | Next Article ![]()
Journal of Bacteriology, March 2003, p. 1768-1775, Vol. 185, No. 6
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.6.1768-1775.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata 940-2188,1 Graduate School of Bio-Applications and Systems Engineering, Tokyo University of Agriculture and Technology, Koganei, Tokyo 184-8588, Japan2
Received 12 August 2002/ Accepted 11 December 2002
|
|
|---|
-(2-methoxyphenoxy)-ß-hydroxypropiovanillone (MPHPV), was transformed by LigF or LigE to guaiacol and
-glutathionyl-ß-hydroxypropiovanillone (GS-HPV). This result suggested that LigF and LigE catalyze the nucleophilic attack of glutathione on the carbon atom at the ß position of MPHPV. High-pressure liquid chromatography-circular dichroism analysis indicated that LigF and LigE each attacked a different enantiomer of the racemic MPHPV preparation. The ligG gene product specifically catalyzed the elimination of glutathione from GS-HPV generated by the action of LigF. This reaction then produces an achiral compound, ß-hydroxypropiovanillone, which is further degraded by this strain. Disruption of the ligF, ligE, and ligG genes in SYK-6 showed that ligF is essential to the degradation of one of the MPHPV enantiomers, and the alternative activities which metabolize the substrates of LigE and LigG are present in this strain. |
|
|---|
-dehydrogenase (LigD), which oxidized a typical model compound of ß-aryl ether, guaiacylglycerol-ß-guaiacyl ether, to
-(2-methoxyphenoxy)-ß-hydroxypropiovanillone (MPHPV). It has been thought that the ether linkage of MPHPV was reductively cleaved by the two kinds of ß-etherases, the gene products of ligE (LigE) and ligF (LigF), to produce ß-hydroxypropiovanillone (HPV) and guaiacol in the presence of glutathione (11, 12). HPV seemed to be degraded through side chain cleavage and the vanillate degradation pathway. The deduced amino acid sequences of LigE and LigF possessed up to 27% identity with eukaryotic glutathione S-transferases (GSTs), and the identity between LigE and LigF was only 18%. In addition to these genes, another GST gene, ligG, the deduced amino acid sequence of which had approximately 20% identity with those of both LigE and LigF, was found to be located just downstream of ligE (13). However, the ligG gene product (LigG) showed no ß-etherase activity, and its role remained unknown. GSTs are well known in eukaryotes as the enzymes that catalyze the formation of the glutathione conjugates of a wide range of compounds. Based on studies of sequence similarity, GSTs have been classified into 11 categories (28). Information regarding bacterial GSTs is limited, although many proteobacteria contain large sets of GST genes with widely divergent sequences (28). Here, we clarify the concrete roles of the tandemly located GST genes of S. paucimobilis SYK-6 in ß-aryl ether cleavage.
![]() View larger version (27K): [in a new window] |
FIG. 1. Organization of the ligDFEG gene cluster (A) and deduced functions of the gene products in the ß-aryl ether cleavage (B). (A) The ligD, ligF, ligE, and ligG genes are indicated by the thick arrows. Vertical bars above the restriction map indicate the positions of the Kmr gene insertions of ligF (FK10), ligE (EK22), and ligG (GK12) mutants. Abbreviations for restriction enzymes: Ap, ApaI; Bs, BstXI; E, EcoRI; Ec, Eco47III; Ml, MluI; P, PstI; RV, EcoRV; S, SalI; Sc, SacI; ScII, SacII; St, StuI; Sm, SmaI; Tt, Tth111I; and X, XhoI. (B) GGE, guaiacylglycerol-ß-guaiacyl ether; GSH, glutathione; GSSG, glutathione disulfide. Asterisks indicate the asymmetric carbons.
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids used in this study
|
-O-(ß-methylumbelliferyl)acetovanillone (MUAV) were prepared in a previous study (14). The purity of these substrates was estimated to be more than 99% by gas chromatography-mass spectrometry (MS) analysis. Guaiacol was purchased from Tokyo Kasei Kogyo Co. (Tokyo, Japan). Enzyme assay. The etherase activities of LigF and LigE toward the fluorescent substrate MUAV were fluorometrically assayed. The 2-ml reaction mixture contained 30 µM MUAV, 1 mM glutathione, and appropriate concentrations of the enzyme in 20 mM Tris-HCl (pH 7.5) (buffer A), and the reaction was carried out at 25°C. Formation of 4-methylumbelliferone (4MU) in the LigF reaction mixture was monitored in a 10-s continuous assay by using an RF-1500 fluorometric analyzer (Shimadzu, Kyoto, Japan). In the case of the LigE reaction, 100 µl of the reaction mixture was taken at 5 min and added to 1.9 ml of 100 mM glycine-NaOH buffer (pH 10.0), and formation of 4MU was determined with the RF-1500 analyzer. One unit of the enzyme was defined as the amount that released 1 µmol of 4MU/min from the substrate. Specific activity was expressed as units per milligram of protein.
The etherase activities of LigF and LigE toward MPHPV were determined by measuring the decrease in substrate by high-pressure liquid chromatography (HPLC) analysis. The 1-ml assay mixture contained buffer A, 50 µM MPHPV, 1 mM glutathione, and the cell extract of E. coli BL21(DE3) harboring pETF48 (100 µg of protein/ml) or pETE10 (1 mg of protein/ml). Reactions were carried out at 25°C and stopped by the addition of methanol (final concentration, 25%) at 15 s for the LigF reaction and at 5 min for the LigE reaction. Precipitated protein was removed by centrifugation (15,000 x g for 10 min), and the supernatant was analyzed with an Alliance 2690 Separations Module HPLC system (Waters, Milford, Mass.) equipped with a TSKgel ODS-80TM column (6 by 150 mm; Tosoh, Tokyo, Japan). The mobile phase was a mixture of water (49.5%), acetonitrile (49.5%), and phosphate (1.0%), and the flow rate was 1.0 ml/min. Compounds were detected at 280 or 310 nm. One unit of the enzyme was defined as the amount that degrades 1 µmol of MPHPV/min. Specific activity was expressed as units per milligram of protein.
GST activities of LigF toward 1-chloro-2,4-dinitrobenzene (1 mM), p-nitrobenzyl chloride (1 mM), and 1,2-epoxy-3-p-nitrophenoxypropane (0.5 mM) were assayed by incubating LigF (10 µg of protein/ml) with the substrates in a 2-ml reaction mixture containing 20 mM potassium phosphate buffer (pH 6.5) and 1 mM glutathione at 25°C. Each activity was monitored by the increase in absorbance at 340, 310, and 360 nm derived from the production of glutathione conjugates of 1-chloro-2,4-dinitrobenzene, p-nitrobenzyl chloride, and 1,2-epoxy-3-p-nitrophenoxypropane, respectively, with a DU-7500 spectrophotometer (Beckman, Fullerton, Calif.).
Preparation of cell extract and LigF purification. Cells of E. coli BL21(DE3) transformants harboring pETF48, pETE10, and pETG9, carrying ligF (DDBJ accession no. D11473), ligE (DDBJ accession no. D11473), and ligG (DDBJ accession no. AB026292), respectively, were grown in 200 ml of LB medium containing 100 mg of ampicillin/liter at 37°C. The expression of the genes was induced for 4 to 5 h by adding isopropyl-ß-D-thiogalactopyranoside (final concentration, 1 mM) when the turbidity of the culture at 660 nm reached 0.5. Cells were harvested by centrifugation and sonicated in buffer A. The cell lysate was centrifuged at 15,000 x g for 15 min. The supernatant was then used as a crude enzyme. For purification of LigF, streptomycin (final concentration, 1%) was added to the supernatant, and it was centrifuged at 100,000 x g for 60 min. Enzyme purification was performed according to the method described below by using a BioCAD700E apparatus (PerSeptive Biosystems, Framingham, Mass.). The crude LigF enzyme was applied to a POROS HQ (quaternized polyethyleneimine) column (4.6 by 100 mm) (PerSeptive Biosystems) previously equilibrated with buffer A containing 100 mM NaCl. The enzyme was eluted with the same buffer, and fractions containing etherase activity toward MUAV were pooled. After these fractions were concentrated and desalted, ammonium sulfate was added to the enzyme solution to a final concentration of 2 M. The enzyme solution was centrifuged at 3,000 x g for 10 min, and the supernatant was applied to a POROS PE (phenyl ether) column (4.6 by 100 mm) (PerSeptive Biosystems) equilibrated with buffer A containing 2 M ammonium sulfate. The enzyme was eluted with 25 ml of a linear gradient of 2.0 to 0 M ammonium sulfate. The fractions containing etherase activity that eluted at 0.93 M were collected. Glycerol was added to a final concentration of 20%, and the purified enzyme was stored at -80°C until used.
Analysis of the reaction product. The 10-ml assay mixture contained buffer A, 50 µM MPHPV, 100 µM glutathione, and the purified LigF (10 µg of protein/ml) or the cell extract of E. coli BL21(DE3) harboring pETE10 (100 µg of protein/ml). Reactions were carried out at 25°C and were stopped by the addition of methanol (final concentration, 25%) at 10 min for the LigF reaction and at 60 min for the LigE reaction. Precipitated protein was removed by centrifugation (15,000 x g for 10 min), and the supernatant was analyzed with the HPLC system by the method described above and by electrospray ionization (ESI)-MS (HP1100 series LC-MSD; Hewlett-Packard Co., Palo Alto, Calif.). In the analysis by ESI-MS, mass spectra were obtained by negative-mode ESI, with a needle voltage of -3.5 kV and a source temperature of 330°C. The mobile phase was a mixture of water (90%) and methanol (10%), and the flow rate was 0.25 ml/min.
To determine the enantioselectivities of LigF and LigE toward MPHPV enantiomers, 50 µM MPHPV was incubated with the purified LigF (10 µg of protein/ml) in a 10-ml reaction mixture containing buffer A and 1 mM glutathione at 25°C. A portion of the reaction mixture (1 ml) was taken for HPLC analysis, and conversion of 50% of MPHPV to
-glutathionyl-HPV (GS-HPV) was confirmed by HPLC analysis. After the LigF reaction, crude LigE enzyme (100 µg of protein/ml) was added to this reaction mixture (total volume, 9 ml) and incubated for 60 min at 25°C. The reaction mixture was then analyzed by HPLC.
To analyze which enantiomer of MPHPV was degraded by LigF, the MPHPV preparation remaining after the reaction with LigF was analyzed with an HPLC system (Jasco Corp., Tokyo, Japan) equipped with a CHIRAL OD column (4.6 by 250 mm; Daicel Chemical Industries, Tokyo, Japan). The 5-µg MPHPV preparation was dissolved in tetrahydrofuran and separated on this HPLC system. The mobile phase was a mixture of hexane (74.5%), ethanol (24.5%), and acetic acid (1.0%), and the flow rate was 0.5 ml/min. MPHPV enantiomers were detected at 300 nm by a CD-2095 detector (Jasco). The MPHPV preparation (100 µM) was incubated with the cell extract of E. coli BL21(DE3) harboring pETF48 carrying ligF (100 µg of protein/ml) in a 100-ml reaction mixture containing buffer A and 1 mM glutathione at 25°C. The reaction mixture was acidified with hydrochloric acid, extracted with ethyl acetate, and separated by thin-layer chromatography with chloroform-ethyl acetate-formic acid (10:8:1), and then the spot of MPHPV was cut out and extracted with ethyl acetate. The sample (approximately 3 µg) was finally dissolved in tetrahydrofuran and separated on a chiral HPLC-circular dichroism (CD) system.
For detection of LigG activity, GS-HPV I and II were prepared in a 10-ml reaction mixture containing buffer A, 50 µM MPHPV, 1 mM glutathione, and the purified LigF (10 µg of protein/ml) or the cell extract of E. coli BL21(DE3) harboring pETE10 (100 µg of protein/ml), respectively, at 25°C. A portion of the reaction mixture (1 ml) was taken for HPLC analysis to confirm that half of the MPHPV preparation was transformed to GS-HPV. The mixtures containing GS-HPV I or II were incubated with the cell extract of E. coli BL21(DE3) harboring pETG9 (10 µg of protein/ml) for 10 min or with the same extract (500 µg protein/ml) for 60 min, respectively, in a 9-ml reaction mixture at 25°C. These mixtures were analyzed by HPLC as described above. HPV generated in these reactions was identified by comparing the retention time and the UV-visible spectrum with those of the authentic HPV.
Analytical methods. The protein concentration was determined by the method of Bradford (6). The expression of the genes was examined by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis (SDS-12% PAGE) (10). The molecular mass of the native LigF was determined by Superdex 200 HR10/30 (Pharmacia Biotech, Milwaukee, Wis.) gel filtration column chromatography with BioCAD700E. Elution was performed with 50 mM potassium phosphate buffer (pH 7.5) containing 0.15 M NaCl at a flow rate of 0.8 ml/min. The molecular weight was estimated on the basis of the calibration curve of reference proteins. The isoelectric point of LigF was determined by isoelectric focusing with an Ampholine PAG plate (pH 3.5 to 9.5) (Pharmacia Biotech), using a model Mutiphor II electrophoresis system (Pharmacia Biotech). Gas chromatography-MS analysis was performed as described previously (17).
Construction of insertion mutants of S. paucimobilis SYK-6. DNA manipulations were carried out essentially as described previously (4, 22). Construction of each gene-disrupted plasmid was carried out as follows. The 0.3- and 0.1-kb EcoRI fragments were replaced with the 1.3-kb kanamycin resistance (Kmr) gene of pUC4K in the 3.0-kb EcoRV-MluI fragment carrying ligFE in order to disrupt ligF in plasmid pBSEM3. The 3.7-kb ligF-inactivated fragment of the resulting plasmid was cloned into pK19mobsacB (23) to construct pMSF37. The 0.3-kb BstXI-Tth111I fragment was replaced with the Kmr gene in pBSEM3 to disrupt ligE. The 3.8-kb ligE-inactivated fragment was cloned in pK19mobsacB to construct pMSE38. The 0.2-kb Eco47III-MluI fragment was replaced with the Kmr gene to disrupt ligG in the 1.8-kb PstI fragment in pUCP18. The 2.8-kb ligG-inactivated fragment of the resulting plasmid was cloned in pK19mobsacB to construct pMSG28. These plasmids were introduced into SYK-6 by electroporation. The selection of each gene-disrupted mutant was made as described previously (17). To examine the disruption of each gene, Southern hybridization analysis was performed. The total DNAs of candidates for the ligF and ligE mutants and for the ligG mutant were digested with EcoRV and MluI and with SalI, respectively. The 1.3-kb SalI fragment carrying the Kmr gene, the 1.7-kb XhoI fragment carrying ligF and part of ligE, and the 0.6-kb SacI-SalI fragment carrying part of ligG were labeled with the digoxigenin system (Roche Molecular Biochemicals, Mannheim, Germany) and used as probes.
Cell extracts of SYK-6 and its mutants were prepared from cells grown on LB medium and on the same medium containing 50 mg of kanamycin per liter, respectively, by the method described above. Each cell extract (1 mg of protein/ml) was incubated with 50 µM MPHPV at 25°C in a 10-ml reaction mixture containing buffer A and 2 mM glutathione and was analyzed by HPLC.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Purification of LigF from E. coli BL21(DE3) harboring pETF48
|
![]() View larger version (107K): [in a new window] |
FIG. 2. SDS-PAGE analysis of protein fractions. Proteins were separated on an SDS-12% polyacrylamide gel and stained with Coomassie brilliant blue. Lanes: 1, molecular mass markers; 2, crude extract of E. coli BL21(DE3) harboring pET21(+) (10 µg of protein); 3, cell extract of E. coli BL21(DE3) harboring pETF48 (10 µg of protein); 4, HQ fraction (3 µg of protein); 5, PE fraction (1.5 µg of protein). Molecular masses are given on the left.
|
![]() View larger version (25K): [in a new window] |
FIG. 3. Identification of the reaction products from MPHPV catalyzed by LigF. Purified LigF was incubated with the MPHPV preparation in the presence of glutathione. (A and B) HPLC chromatograms at 0 and 10 min of incubation, respectively. Compounds were detected at 280 nm. (C and D) ESI-MS spectra of the reaction mixtures at 0 and 10 min of incubation, respectively. GSH, glutathione; AU, absorbance units.
|
![]() View larger version (21K): [in a new window] |
FIG. 4. Chiral HPLC-CD analysis of LigF enantioselectivity. (A and B) The MPHPV preparation was separated on a chiral column by HPLC and was detected with CD (A) and UV (B) detectors. (C and D) After incubation of the MPHPV preparation with LigF, the remaining MPHPV was analyzed by HPLC and detected with CD (C) and UV (D) detectors.
|
![]() View larger version (37K): [in a new window] |
FIG. 5. Disruption of ligF, ligE, and ligG in S. paucimobilis SYK-6. (A) Southern hybridization analysis of the insertion mutants. Lanes: 1, 3, 5, and 7, total DNA of SYK-6 digested with EcoRV and MluI; 2 and 4, total DNA of the ligF insertion mutant (FK10) digested with EcoRV and MluI; 6 and 8, total DNA of the ligE insertion mutant (EK22) digested with EcoRV and MluI; 9 and 11, total DNA of SYK-6 digested with SalI; and 10 and 12, total DNA of the ligG insertion mutant (GK12) digested with SalI. The 1.3-kb SalI fragment carrying the Kmr gene (lanes 3, 4, 7, 8, 11, and 12), the 1.7-kb XhoI fragment carrying ligF and part of ligE (lanes 1, 2, 5, and 6), and the 0.6-kb SacI-SalI fragment carrying part of ligG (lanes 9 and 10) were used as probes. (B) Degradation of MPHPV by cell extracts of SYK-6 (circles), FK10 (triangles), and EK22 (squares) in the presence of glutathione. The rate of transformation of MPHPV by the cell extract of GK12 was at the same level as that for SYK-6. Error bars indicate standard deviations.
|
![]() View larger version (33K): [in a new window] |
FIG. 6. Detection of the glutathione lyase activity of LigG. (A and C) HPLC chromatograms of the substrates, GS-HPV I and GS-HPV II, generated from the MPHPV preparation by the actions of LigF and LigE enzymes, respectively, in the presence of glutathione. (B) HPLC chromatogram of the reaction product of GS-HPV I incubated for 10 min with the cell extract of E. coli BL21(DE3) harboring pETG9 (10 µg of protein/ml). (D and E) HPLC chromatograms of the reaction products of GS-HPV II incubated for 60 min with the cell extract of E. coli BL21(DE3) harboring pETG9 (500 µg of protein/ml) and with the cell extract of E. coli BL21(DE3) harboring pET21(+) (500 µg of protein/ml), respectively. AU, absorbance units.
|
Among the three GSTs characterized here, only ligF was essential to MPHPV degradation. LigE and LigG were able to attack MPHPV II and GS-HPV I, respectively, but these compounds were metabolized by the alternative activities in SYK-6. It is most likely that an additional set of enantioselective GSTs are involved in these reaction steps. Isolation of the enzyme gene(s) involved in MPHPV II degradation is under way in our laboratory.
|
|
|---|
-dehydrogenase gene involved in the cleavage of ß-aryl ether by Pseudomonas paucimobilis. Biosci. Biotechnol. Biochem. 57:1655-1659.[Medline]
ZAP: a bacteriophage
expression vector with in vivo excision properties. Nucleic Acids Res. 16:7583-7600.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»